...
首页> 外文期刊>Journal of Clinical Microbiology >Factors Contributing to Variability of Quantitative Viral PCR Results in Proficiency Testing Samples: a Multivariate Analysis
【24h】

Factors Contributing to Variability of Quantitative Viral PCR Results in Proficiency Testing Samples: a Multivariate Analysis

机译:能力验证样品中定量病毒PCR结果变异性的影响因素:多变量分析

获取原文
           

摘要

While viral load testing has gained widespread acceptance, a primary limitation remains the variability of results, particularly between different laboratories. While some work has demonstrated the importance of standardized quantitative control material in reducing this variability, little has been done to explore other important factors in the molecular amplification process. Results of 185 laboratories enrolled in the College of American Pathologists (CAP) 2009 viral load proficiency testing (PT) survey (VLS) were examined. This included 165 labs (89.2%) testing for cytomegalovirus (CMV), 99 (53.5%) for Epstein-Barr virus (EBV), and 64 (34.6%) for BK virus (BKV). At the time of PT, laboratories were asked a series of questions to characterize their testing methods. The responses to these questions were correlated to mean viral load (MVL) and result variability (RV). Contribution of individual factors to RV was estimated through analysis of variance (ANOVA) modeling and the use of backward selection of factors to fit those models. Selection of the quantitative calibrator, commercially prepared primers and probes, and amplification target gene were found most prominently associated with changes in MVL or RV for one or more of the viruses studied. Commercially prepared primers and probes and amplification target gene made the largest contribution to overall variability. Factors contributing to MVL and RV differed among viruses, as did relative contribution of each factor to overall variability. The marked variability seen in clinical quantitative viral load results is associated with multiple aspects of molecular testing design and performance. The reduction of such variability will require a multifaceted approach to improve the accuracy, reliability, and clinical utility of these important tests.
机译:尽管病毒载量测试已被广泛接受,但主要的限制仍然是结果的可变性,尤其是在不同实验室之间。尽管一些工作证明了标准化定量控制材料在减少这种变异性方面的重要性,但在分子扩增过程中探索其他重要因素的工作却很少。检查了美国病理学家学院(CAP)2009病毒载量能力测试(PT)调查(VLS)招募的185个实验室的结果。其中包括165个实验室(89.2%)的巨细胞病毒(CMV)测试,99个实验室(53.5%)的爱泼斯坦-巴尔病毒(EBV)和64个(34.6%)的BK病毒(BKV)测试。在PT时代,实验室被问了一系列问题以表征其测试方法。对这些问题的回答与平均病毒载量(MVL)和结果变异性(RV)相关。通过方差分析(ANOVA)建模以及使用向后选择因子以拟合这些模型来估算单个因素对RV的贡献。对于一种或多种研究的病毒,发现定量校准物,商业制备的引物和探针以及扩增靶基因的选择与MVL或RV的变化最显着相关。商业制备的引物和探针以及扩增靶基因对总体变异性的贡献最大。病毒中导致MVL和RV的因素有所不同,每种因素对总体变异性的相对影响也有所不同。在临床定​​量病毒载量结果中看到的明显变异性与分子测试设计和性能的多个方面相关。减少此类变异性将需要采取多方面的方法来提高这些重要测试的准确性,可靠性和临床实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号